EZH2 and systemic lupus erythematosus: In systemic lupus erythematosus, the immune tolerance of B cells is disrupted, leading to overproduction of autoantibodies and exacerbation of autoimmune responses, and inhibition of EZH2 repairs this immune tolerance and reduces autoantibody production in pristane-induced lupus mice (Yang et al. 2023).